Associate Chief Physician. He has long been working on the front lines of clinical cardiac surgery, participating in approximately 5,000 operations and performing nearly 1,000 primary operations. Among these, grade III and IV operations account for over 90%, complex operations exceed 20%, and the success rate of primary operations is above 99%. His main research directions include surgical treatment of complex congenital heart disease, non-pharmacological therapy for severe pulmonary hypertension, thoracoscopic surgical treatment of atrial appendage-originated arrhythmias, and transitional care for adult congenital heart disease.

He specializes in minimally invasive surgery for congenital heart diseases such as ventricular septal defect and atrial septal defect, surgical treatment of congenital heart diseases including tetralogy of Fallot, atrioventricular septal defect, aortic arch coarctation and vascular ring, as well as thoracoscopic minimally invasive treatment of chest wall deformities, congenital pulmonary diseases and mediastinal tumors.